Philip Gregory, D.Phil.


Philip Gregory, D.Phil. is the chief scientific officer of bluebird bio, has been an ASGCT member since 2004, and has served as a member of both the Program Committee and Advisory Council. Through more than 15 years in the filed, Gregory has developed the basic science, discovery and translation of genome editing technologies for clinical applications. His experience in biotech and as a translational specialist will be invaluable to the Society as it balances an ever-growing list of stakeholders.

2019
ASGCT Policy Summit
November 4 – 6 | Washington D.C.
Close